General MedicationsINTRAVENOUSStandard
CYCLOPHOSPHAMIDE
CYCLOPHOSPHAMIDE
Standard Dose
2GM/10ML (200MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview CYCLOPHOSPHAMIDE is listed in Drugs@FDA under application 212501 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient CYCLOPHOSPHAMIDE Form and strength SOLUTION;INTRAVENOUS - 2GM/10ML (200MG/ML) Sponsor DR REDDYS Submission history Latest submission status date: 2025-03-11 00:00:00.
Structured Monograph
Clinical summary
Approval overview CYCLOPHOSPHAMIDE is listed in Drugs@FDA under application 212501 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CYCLOPHOSPHAMIDE Form and strength SOLUTION;INTRAVENOUS - 2GM/10ML (200MG/ML) Sponsor DR REDDYS Submission history Latest submission status date: 2025-03-11 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.